Ask AI

Innovations in HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: A Practical Skills Course on New and Emerging Targeted Therapies

Enhance your understanding of targeted therapies for HER2+ gastroesophageal adenocarcinoma and biliary tract cancer based on current and emerging clinical evidence, and learn how to select patients for optimal benefit from HER2-direct therapies through an interactive decision support tool, downloadable patient checklist resource and infographic, on-demand webcast, interactive case challenges, podcasts, an expert-authored commentary, and downloadable slides.

Share

Program Content

Events

  • Live Event
    Innovations in HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: A Practical Skills Course on New and Emerging Targeted Therapies
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Understanding Tx Options for HER2+ GEA and BTC
Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 24, 2025

HER2 Positive Advanced BTC and GEA
HER2-Directed Therapies for HER2-Positive Advanced BTC and GEA for Patients and Their Caregivers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

Activities

HER2 Directed Therapies for BTC and GEA
Innovations in HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: A Practical Skills Course on New and Emerging Targeted Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2026

Activities

Management of Progressive BTC
Management of a Patient With Progressive Biliary Tract Cancer After Standard of Care Gemcitabine/Cisplatin Plus an Immune Checkpoint Inhibitor
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2025

Expires: June 29, 2026

Management of HER2pos GEA
Management of a Patient With HER2-Positive Advanced Gastroesophageal Adenocarcinoma
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2026

Expires: August 08, 2026

Activities

Treatment of HER2pos GEA and BTC
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients, Inc.

Supporters

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.

Partners

Smart Patients, Inc.

ProCE Banner